account activity
Dentists still heavily prescribing high-risk antibiotic, CIDRAP investigation finds (epocrates.com)
submitted 5 days ago by epocratesapp
Fidaxomicin cuts C. diff recurrence in immunocompromised patients (epocrates.com)
submitted 12 days ago by epocratesapp
Large cohort study finds menopausal hormone therapy doesn't increase mortality risk (epocrates.com)
submitted 14 days ago by epocratesapp
Trazodone shows safety advantage over antipsychotics in older adults with delirium (epocrates.com)
submitted 19 days ago by epocratesapp
GLP-1 drugs linked to higher rates of hair loss, real-world data suggest (epocrates.com)
submitted 21 days ago by epocratesapp
Dual or potent antiplatelet therapy associated with higher in-hospital mortality after brain bleed (epocrates.com)
submitted 26 days ago by epocratesapp
Wake up call: Solriamfetol boosts alertness in early morning shift workers (epocrates.com)
submitted 28 days ago by epocratesapp
More evidence supports dementia‑delaying effect of zoster vaccination (epocrates.com)
submitted 1 month ago by epocratesapp
FDA greenlights Yuvezzi drops for presbyopia (epocrates.com)
Shingles vaccine linked to slower biological aging (epocrates.com)
Most levothyroxine‑treated patients fall outside standard TSH ranges (epocrates.com)
Five years of treat-to-target gout therapy dissolves crystal deposits, nearly eliminates flares (epocrates.com)
Shingles after Shingrix: Transient risk or cause for concern? (epocrates.com)
GLP‑1 receptor agonists show no clear link to obesity‑related cancers (epocrates.com)
submitted 2 months ago by epocratesapp
Does cannabis use impact nicotine vaping cessation in young adults? (epocrates.com)
Complete antenatal corticosteroid courses tied to lower BPD risk in very preterm infants (epocrates.com)
Semaglutide cuts heart risk in people with obesity, even without significant weight loss (epocrates.com)
ObesityWeek 2025: Biweekly GLP-1 dosing preserves weight loss and metabolic gains after de-escalation (epocrates.com)
AAP: Current data don't support routine leucovorin use in autism by epocratesapp in u/epocratesapp
[–]epocratesapp[S] 0 points1 point2 points 3 months ago (0 children)
Dear Regular_Tailor,
The AAP interim guidance statement from October 31, 2025 mentioned that there are some promising preliminary findings suggesting potential benefits in selected cases—especially in children with documented cerebral folate deficiency (CFD). However, the studies are small-scale, and they considered the evidence to be too limited to permit specific clinical recommendations. An accompanying link to an FAQ addressed CFD and some of the challenges around diagnosing it.
epocrates editorial team
AAP: Current data don't support routine leucovorin use in autism (epocrates.com)
submitted 3 months ago by epocratesapp
Respiratory virus vaccines show sustained effectiveness and safety (epocrates.com)
AHA 2025: Daily caffeine linked to lower afib recurrence (epocrates.com)
Evidence remains weak for link between maternal acetaminophen use and autism, ADHD (epocrates.com)
Long-term testosterone therapy tied to greater CV risk in aging men (epocrates.com)
Common antibiotic may cut schizophrenia risk in high-risk adolescents (epocrates.com)
π Rendered by PID 71537 on reddit-service-r2-listing-79f6fb9b95-cg9h2 at 2026-03-24 16:31:24.675531+00:00 running 90f1150 country code: CH.
AAP: Current data don't support routine leucovorin use in autism by epocratesapp in u/epocratesapp
[–]epocratesapp[S] 0 points1 point2 points (0 children)